Cash Flow - Tango Therapeutics, Inc. (TNGX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -138.89 | -131.50 | -117.98 | -109.08 | -59.53 | 70.07 | -24.80 |
| Cash flow from investing | -40.87 | 86.13 | 41.43 | 26.40 | -183.43 | -145.47 | 0.85 |
| Cash flow from financing | 222.50 | 47.66 | 82.41 | 1.62 | 357.33 | 80.88 | 11.00 |
| Change in cash | 42.75 | 2.29 | 5.85 | -81.07 | 114.36 | 5.49 | -12.96 |
Show Quarterly Cash Flow
Cash Flow - Tango Therapeutics, Inc. (TNGX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -44.36 | -29.72 | -30.95 | -36.52 | -41.70 | -36.65 | -33.39 | -23.61 | -37.86 | -27.47 | -31.14 | -24.47 | -34.91 | -28.27 | -19.61 | -31.54 | -29.67 | -16.90 | -21.49 | -7.52 | -13.61 | -18.06 | 111.26 | -11.00 | -12.13 |
| Cash flow from investing | 9.64 | -135.72 | 47.48 | 16.78 | 30.60 | 52.06 | 32.57 | 12.70 | -11.20 | 33.85 | -56.66 | 32.69 | 31.55 | -12.61 | 15.23 | 35.49 | -11.72 | -45.21 | -152.21 | -6.63 | 20.61 | -59.21 | -69.75 | -28.40 | 11.89 |
| Cash flow from financing | 79.85 | 219.38 | 2.54 | 0.58 | 0.00 | 0.97 | 2.40 | 1.31 | 42.98 | 1.47 | 80.28 | 0.59 | 0.07 | 0.53 | 0.11 | 0.72 | 0.26 | -0.12 | 327.78 | -0.75 | 30.41 | -0.06 | 51.09 | 29.86 | 29.86 |
| Change in cash | 45.12 | 53.94 | 19.07 | -19.16 | -11.10 | 16.38 | 1.58 | -9.60 | -6.08 | 7.85 | -7.52 | 8.80 | -3.28 | -40.34 | -4.27 | 4.67 | -41.13 | -62.23 | 154.07 | -14.89 | 37.41 | -77.33 | 92.60 | -9.53 | 29.62 |